Harris Rotman

CNTA

Harris Rotman serves as SVP Regulatory Affairs at Centessa Pharmaceuticals plc (CNTA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$303.9K

Net Position

Net Seller

$303.9K

Companies Traded

CNTA

Active Period

Sep 2023 – Feb 2024

2 total trades

Most Recent

Sell CNTA

Feb 1, 2024 · $68.2K

Harris Rotman's Insider Trading at Centessa Pharmaceuticals plc (CNTA)

Buys

0 · $0.00

Sells

2 · $303.9K

Total Shares Bought

Total Shares Sold

45,859

CNTA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 1, 2024	Sell	8,375	$8.15	$68.2K	0
Sep 20, 2023	Sell	37,484	$6.29	$235.7K	0

Related Insiders

Mario Alberto Accardi

President, Orexin Program

CNTASell · Feb 1, 2026

Karen M. Anderson

Chief People Officer

CNTASell · Feb 1, 2026

Tia L Bush

Chief Technology & Quality Ofc

CNTASell · Feb 1, 2026

Gregory M Weinhoff

Chief Business Officer

CNTASell · Feb 1, 2026

HUSSAIN IQBAL J

General Counsel

CNTASell · Jan 30, 2026

Explore More Insider Trading Data

CNTA Insider Trading Activity

View all insider trades at Centessa Pharmaceuticals plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity